Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents
暂无分享,去创建一个
A. Ferrari | A. Gronchi | M. Massimino | A. Parafioriti | P. Collini | R. Luksch | C. Meazza | F. Spreafico | M. Podda | D. Polastri | L. Gandola | M. Terenziani | M. Casanova | E. Schiavello | P. Daolio | V. Biassoni | A. Luzzati | E. Pecori
[1] R. Grimer,et al. Osteosarcoma of the pelvis. , 2016, The bone & joint journal.
[2] KyungMann Kim,et al. Contrasting treatment‐specific survival using double‐robust estimators , 2012 .
[3] S. Ferrari,et al. Osteosarcoma of the pelvis: a monoinstitutional experience in patients younger than 41 years. , 2012, Tumori.
[4] A. Niemierko,et al. Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma , 2011, Cancer.
[5] L. Kaban,et al. Osteosarcoma of the jaws: factors influencing prognosis. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[6] S. Bielack,et al. The role of radiotherapy in oseosarcoma. , 2009, Cancer treatment and research.
[7] E. Sturgis,et al. Osteosarcoma of the jaw/craniofacial region , 2009, Cancer.
[8] S. Ferrari,et al. High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions , 2008, Journal of surgical oncology.
[9] Paul A Meyers,et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Piero Picci,et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy , 2006, Cancer.
[11] S. Ferrari,et al. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] C. Rodríguez-Galindo,et al. Osteosarcoma of the pelvis in children and young adults: The St. Jude Children's Research Hospital experience , 2005, Cancer.
[13] M. Gebhardt,et al. Malignant Tumors of the Pelvis: An Outcome Study , 2004, Clinical orthopaedics and related research.
[14] Marco Manfrini,et al. Neoadjuvant chemotherapy for high‐grade central osteosarcoma of the extremity , 2003, Cancer.
[15] W. Winkelmann,et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Toshifumi Ozaki,et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] A. McTiernan,et al. A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] J. Shah,et al. Improved outcomes in patients with osteogenic sarcoma of the head and neck , 2002, Cancer.
[19] E. van Marck,et al. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. , 2002, European journal of cancer.
[20] R. Souhami,et al. A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma , 1999 .
[21] S. Bielack,et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] Ø. Bruland,et al. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. , 1997, European journal of cancer.
[23] A. Huvos,et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] W. Meyer,et al. Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis , 1992, Cancer.
[25] N. Jaffe,et al. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumor , 1985, Cancer.
[26] J. Lukens,et al. Treatment of patients with metastatic osteogenic sarcoma: a report from the Children's Cancer Study Group. , 1984, Cancer treatment reports.
[27] D. Groggel. Practical Nonparametric Statistics , 1972, Technometrics.
[28] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[29] S. Bielack,et al. Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS). , 1995, Medical and pediatric oncology.
[30] W. Enneking,et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. , 1993, Clinical orthopaedics and related research.